Loading clinical trials...
Loading clinical trials...
A Descriptive Study to Evaluate the Effectiveness of the Dye Compound of the Combination of Lutein, Zeaxanthin and Brilliant Blue in Chromovitrectomy
The aim of this study is to test the efficacy of the combination of dye Lutein, Zeaxanthin and brilliant blue to stain the internal limiting membrane as well as the epiretinal membranes during the Vitrectomy surgery.
Twenty five patients with epiretinal membrane, macular hole or proliferative diabetic retinopathy and indication of vitrectomy surgery will be selected to participate in this study.
Age
18 - 90 years
Sex
ALL
Healthy Volunteers
No
Depto. of Ophthalmology - Hospital São Paulo - UNIFESP
São Paulo, São Paulo, Brazil
Start Date
October 1, 2012
Primary Completion Date
January 1, 2014
Completion Date
March 1, 2014
Last Updated
March 16, 2016
18
ACTUAL participants
Dye of Lutein, Zeaxanthin and Brilliant Blue
OTHER
Lead Sponsor
Federal University of São Paulo
NCT06719739
NCT06927544
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions